ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0505

Longitudinal Trajectories of Central Pain Sensitization in People with or at Risk of Knee Osteoarthritis

Kosaku Aoyagi1, Na Wang2, Laura Frey-Law3, Cora E. Lewis4, Michael Nevitt5 and Tuhina Neogi2, 1Boston University, Quincy, MA, 2Boston University School of Medicine, Boston, MA, 3University of Iowa, Iowa City, IA, 4University of Alabama at Birmingham, Birmingham, AL, 5University of California at San Francisco, Orinda, CA

Meeting: ACR Convergence 2022

Keywords: Osteoarthritis, pain

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Abstracts: Orthopedics, Low Back Pain, and Rehabilitation

Session Type: Abstract Session

Session Time: 3:00PM-4:00PM

Background/Purpose: Central pain sensitization is a major contributor to pain severity in knee osteoarthritis (OA). Central sensitization is induced by neuroplastic changes in the central nervous system, which may potentially occur in response to peripheral input from OA, but may also be present in individuals unrelated to OA (i.e., an inherent trait). Neuroplastic changes are likely affected by numerous biological and sociocultural factors that vary within and between individuals over time. Therefore, patterns in central sensitization over time may also vary and influence pain severity differently. We sought to agnostically identify central sensitization trajectory patterns over nine years and evaluate their associations with pain severity in people with or at risk of knee OA.

Methods: We included participants from the Multicenter Osteoarthritis (MOST) Study, a NIH-funded longitudinal cohort study of persons with or at risk of knee OA. We used data from 60- (the first visit at which central pain sensitization was assessed), 84-, 144-, and 168-month study visits. We assessed central pain sensitivity using pressure pain threshold (PPT) at the wrist, with a lower value reflecting a greater pain sensitivity. We agnostically identified wrist PPT trajectory groups over the nine years, using a discrete mixture model clustering. We evaluated the goodness of fit between individuals and corresponding trajectory groups by assessing the posterior probability of group membership. We evaluated the relation of wrist PPT trajectory groups to mean WOMAC pain of both knees at 168-months using linear regression, adjusting for age, sex, BMI, race, depressive symptom, and catastrophizing.

Results: We included 1470 participants (mean age 65.8±7.2, 60% female, mean BMI 30.0±5.9). Four distinct trajectory groups were identified: group 1 [stable low PPT, n=921 (62.3%)], 2 [stable moderate PPT, n=434 (29.5%)], 3 [stable high PPT, n=58 (4.0%)], and 4 [moderate & increasing PPT, n=57 (3.9%)](Figure). Participants characteristics per group are provided in the Table. The median posterior probability of group membership for groups 1-4 were 0.96, 0.85, 0.94, 0.97 respectively. Compared with group 1 (stable low PPT – most sensitized), group 2, 3 and 4 had 0.91 (95%CI -1.3, -0.5), 0.91 (95%CI -1.8, 0.0), and 1.67 (95%CI -2.6, -0.7) lower (better) WOMAC pain score than group 1 at the 168-month visit.

Conclusion: We found distinct central sensitization trajectory patterns over 9 years, which were associated with different levels of pain severity. Stable low PPT over a long period of time (i.e., most pain sensitized) was associated with greatest pain severity. Interestingly, one group appeared to have improvements in PPT over time (becoming less pain sensitized), potentially reflecting central adaptability to nociceptive input. Our findings highlight that some patterns of PPT remain stable over time, suggesting a trait phenomenon, whereas it can change in others, suggesting a potentially responsive phenomenon. These findings provide novel insights into potential contributors to the evolution of pain patterns over time, and support the possibility of pain sensitization being a trait in some, while a changeable state in others.

Supporting image 1

Figure: PPT wrist trajectory groups over 9 years

Supporting image 2

Table: Participant Characteristics


Disclosures: K. Aoyagi, None; N. Wang, None; L. Frey-Law, None; C. Lewis, None; M. Nevitt, None; T. Neogi, Novartis, Pfizer/Lilly, Regeneron.

To cite this abstract in AMA style:

Aoyagi K, Wang N, Frey-Law L, Lewis C, Nevitt M, Neogi T. Longitudinal Trajectories of Central Pain Sensitization in People with or at Risk of Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/longitudinal-trajectories-of-central-pain-sensitization-in-people-with-or-at-risk-of-knee-osteoarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/longitudinal-trajectories-of-central-pain-sensitization-in-people-with-or-at-risk-of-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology